alemtuzumab - CISMeF

Preferred Label : alemtuzumab;

UMLS semantic type : T109 - Organic Chemical; T121 - Pharmacologic Substance; T129 - Immunologic Factor;

Is substance : O;

Details

Origin ID

M0253968;

UMLS CUI

C0383429;

Currated CISMeF NLP mapping
- Alemtuzumab [NCIt concept]
- Alemtuzumab (substance) [SNOMED CT concept]
- alemtuzumab [International Nonproprietary Name]
MeSH narrower concept(s)
- Lemtrada [MeSH concept]
- MabCambath [MeSH concept]
- campath [MeSH concept]
- campath 1G [MeSH concept]
- campath 1H [MeSH concept]
- campath 1M [MeSH concept]
Related record
- Alemtuzumab [MeSH Descriptor]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Alemtuzumab [NCIt concept]
- Alemtuzumab (substance) [SNOMED CT concept]
- Anti-CD52 Monoclonal Antibody [NCIt concept]
- Product containing alemtuzumab (medicinal product) [SNOMED CT concept]
- alemtuzumab [ATC Code]
- alemtuzumab [International Nonproprietary Name]
Validated automatic mappings to BTNT
- alemtuzumab [ATC Code]
Validated automatic mappings to NTBT
- Anti-CD52 Monoclonal Antibody [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients